Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1884 Views
Dr KK Aggarwal 13 March 2021
With input from Dr Monica Vasudev
SARS-CoV-2 More Infectious Than SARS-CoV-1: N-terminal domain (NTD) is the pivotal difference between SARS-CoV-1 and -2. This part of the protein has not really been paid attention to before, but it appears that this is a crucial part for the stability of the protein, said Dr. Mahmoud Moradi, of the University of Arkansas. Researchers noted in simulations that SARS-CoV-1 and SARS-CoV-2 have different ways of changing their shape, and on different time scales. SARS-CoV-1 moves faster, and activates and deactivates, thus not giving it enough time to stick to the human cell as it is not as stable. SARS-CoV-2 is stable and ready to attack. SARS-CoV-2, in its active state, is much more stable than the active state of SARS-CoV-1, thus rendering it a better chance of binding to the human receptor.
The dynamics is much slower for SARS-CoV-2. While SARS-CoV-1 moves between the active and inactive state quite often, SARS-CoV-2 is slow in that sense, giving it a better chance of binding. (Medscape) Pfizer COVID Vaccine Protects Against Asymptomatic Infection: Pfizer/BioNTech COVID-19 vaccine was found to prevent both symptomatic disease as well as asymptomatic infection in a real-world review of Israeli health records. A large case-control study with more than one million people noted that the estimated vaccine effectiveness for documented infection was 46% (95% CI 40-51%) at 14-20 days after one dose of vaccine, and 92% (95% CI 88-95%) at least 7 days after the second dose.
(Medpage Today)
Antibody Titers: Healthcare workers with previous COVID-19 infection, based on laboratory-confirmed serology testing, were reported to have higher antibody titer responses to a single dose of the mRNA COVID-19 vaccine compared to those not previously infected, reports a study published in JAMA. (JAMA)
Dr KK Aggarwal
President CMAAO, HCFI and Past National President IMA
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}